(Q83966961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1 reference

Rajesh Pandey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sadhna Sharma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G K Khuller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

287-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Therapeutic drug monitoring in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Serum Rifampicin Levels in Patients with Tuberculosis : Effect of P-Glycoprotein and CYP3A4 Blockers on its Absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Liposome-encapsulated antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

Development of a liposome formulation of ethambutol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10717540500398076

10.1080/10717540500398076

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16766470%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference